Navigation Links
New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease
Date:10/31/2011

r antibodies and anti-double stranded DNA antibody formation was low in patients with active CD receiving continuous or interrupted CZP therapy over 52 weeks, regardless of concomitant immunosuppressants use at baseline.  
  • Poster 726, October 31, 12:45 – 2:15 pm, Prince Georges Exhibit Hall

  • Following is a guide to additional Cimzia presentations at ACG:

    • Fecal Calprotectin Concentration and Clinical Remission in Patients with Active Crohn's Disease Treated with Certolizumab Pegol: Results from PRECiSE 1
      • Poster 282, October 30, 3:30 – 7:00 pm, Prince Georges Exhibit Hall

    • Fecal Calprotectin Concentration and Clinical Response to Certolizumab Pegol in Patients with Active Crohn's Disease: Results from PRECiSE 2
      • Poster 711, October 31, 12:45 – 2:15 pm, Prince Georges Exhibit Hall

    • Use of Certolizumab Pegol in the Management of Acute Extraintestinal Manifestations of Active Crohn's Disease
      • Poster 740, October 31, 12:45 – 2:15 pm, Prince Georges Exhibit Hall

    To view a full schedule of presentations and poster sessions, please click here.  To schedule an interview with Cem Kayhan, MD, Medical Director at UCB or PRECiSE investigator, William Sandborn, MD (University of California San Diego, La Jolla, CA) please contact Andrea Levin at (770) 970-8352 or Andrea.Levin@ucb.com.

    About Crohn's Disease

    Crohn's disease is a chronic, progressive, destructive disorder that causes inflammation of the gastrointestinal (GI) tra
    '/>"/>

    SOURCE UCB
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients
    2. Cimzia® (certolizumab pegol) Data Showed Broad and Rapid Relief From Burden of Symptoms In Rheumatoid Arthritis Patients
    3. New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
    4. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
    5. UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohns Disease
    6. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohns Disease to be Highlighted at ACG Meeting
    7. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
    8. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
    9. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
    10. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
    11. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... 2014  BC Technical, the nation,s leading non-OEM provider ... a leader in sales, service and installation of GE ... Technical to continue to expand their resources and inventory ... modalities. "We are committed to driving ... , president and CEO of BC Technical. "We set ...
    (Date:8/29/2014)... , August 29, 2014 ... Seed Oil Market by Extraction type (SFE, Cold ... & Personal Care, Pharmaceutical, Food Supplements, Fragrance, & Others) ... by MarketsandMarkets, defines and segments the Amaranth Seed ... the market size in terms of value. The ...
    (Date:8/29/2014)... Aug. 29, 2014   Vittamed Corporation , a neurodiagnostics ... announced today that T. (Teo) Forcht Dagi , MD, ... Board of Directors. " Teo Forcht Dagi ... neurosurgery, medical innovation and venture capital," said Remis Bistras ... to add his clinical, strategic, and entrepreneurial expertise to our ...
    Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2
    ... Sinovac Biotech Ltd. (Nasdaq: SVA ), a ... its preliminary unaudited sales range for the third quarter ... full year 2010. A conference call to discuss these ... on October 25, 2010 at 8:00 a.m. Eastern Time ...
    ... Oct. 23 Optimer Pharmaceuticals, Inc. (Nasdaq: ... from its two fidaxomicin Phase 3 trials in patients ... 48th Annual Meeting of the Infectious Disease Society of ... oral presentation, investigator Derrick Crook, M.D., of the University ...
    Cached Medicine Technology:Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations 2Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations 3Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations 4Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA 2Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA 3Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA 4Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA 5
    (Date:9/1/2014)... 2014 As well as having completed ... currently pursuing counselor certification in Louisiana. , ... CPI training program as well as the Counselor ... both personally and professionally. I am not only ... able to do so. As a Non Violent ...
    (Date:9/1/2014)... York (PRWEB) September 01, 2014 ... retrieve, organize and analyze biological and genetic data. ... the activity of developing software tools to generate ... to be confused with biological computation. While bioinformatics ... understanding of biology can its related concepts, biological ...
    (Date:9/1/2014)... Registration is now open for the 4th Annual ... to be held on Sunday, September 21, 2014. The event ... Meadow in Secaucus, New Jersey. All proceeds from the race ... to restoring a sense of self, restoring the family unit, ... families. , General registration is $30 with special pricing for ...
    (Date:9/1/2014)... Daily Gossip reveals in it's review on Tattoo ... members access to thousands of professionally designed tattoo images ... to help both people who plan on getting a ... for inspiration in creating one of a kind models. ... visiting the official website at: http://www.dailygossip.org/atattoo-me-now-6444 . , ...
    (Date:9/1/2014)... (PRWEB) September 01, 2014 Pastor Thompson is ... Specialist at Eagle Village. He is a licensed minister through ... over the past twenty years in New Mexico, Colorado and ... years of marriage this year. He also has two ... a B.S. in Pastoral Ministry from Nazarene Bible College, in ...
    Breaking Medicine News(10 mins):Health News:Narconon Louisiana Announces New Certifications For Staff 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Tattoo Me Now Review Reveals Unique Ideas for Tattoo Designs 2
    ... experience have developed a weapon against one rapidly lethal war ... armor, where the trunk and legs join, to injure the ... within minutes. , "There is no way to ... in this area and dying within several minutes," said Dr. ...
    ... that previous models used to examine cancer may not ... environment. Using oral cancer cells in a three-dimensional model ... oral cavity, the researchers found that the tissue surrounding ... expression or suppression of a cell adhesion protein associated ...
    ... through hospital emergency departments and operated on within 48 ... by UK experts in anaesthesia, orthopaedics, geriatrics and emergency ... Anaesthesia . However, patients in one in ... than two days, risking lengthier inpatient stays, increased health ...
    ... Reporter , TUESDAY, Jan. 10 (HealthDay News) -- Unlike the ... declines in lung function that could lead to breathing problems, ... that road toward breathlessness, but low to moderate levels of ... there were limits to the study. For example, the findings ...
    ... sister with newly diagnosed cancer can be a distressing and ... there can be a period of adjustment when their school ... Central,s open access journal Child and Adolescent Psychiatry and ... improve the child,s knowledge about their sibling,s disease and to ...
    ... much more likely to develop mental health disorders as ... in clinical psychology at the University of Houston (UH) ... for Kids (SACK). To address this problem ... a clinical research center at UH that provides low-cost, ...
    Cached Medicine News:Health News:Emergency medicine physicians develop device to stop lethal bleeding in soldiers 2Health News:Emergency medicine physicians develop device to stop lethal bleeding in soldiers 3Health News:Lab-made tissue picks up the slack of Petri dishes in cancer research 2Health News:Hip fracture guidelines tackle 'considerable variations' in UK and Irish hospital care 2Health News:Hip fracture guidelines tackle 'considerable variations' in UK and Irish hospital care 3Health News:Occasional Pot Smoking Won't Harm Lungs: Study 2Health News:Occasional Pot Smoking Won't Harm Lungs: Study 3Health News:New educational program helps the siblings of children with cancer 2Health News:University of Houston opens Sleep and Anxiety Center for Kids 2Health News:University of Houston opens Sleep and Anxiety Center for Kids 3
    ... Lyphochek Immunoassay Plus Control provides ... comprehensive control in the world for ... procedures, eliminating the need for separate ... no added preservatives, it is suitable ...
    ... Plus Control is a liquid ... today's busy immunoassay laboratory. With ... human serum based control can ... control products for immunoassay and ...
    Liquichek Immunology Control is a trilevel, liquid, comprehensive serum protein control with assayed values for a wide number of methods....
    ... Detection Platform provides fully automated detection of ... platform for molecular pathology labs separates DNA ... features that deliver a high degree of ... the capacity to run two 96-well plates, ...
    Medicine Products: